ConductScience.org, home

Paper32130708

Ovarian Cancer Biomarkers: Moving Forward in Early Detection.

Bonifácio VDB. Adv Exp Med Biol, 2020. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Ovarian Cancer Biomarkers: Moving Forward in Early Detection. Papers, record 32130708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32130708

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ovarian Cancer Biomarkers: Moving Forward in Early Detection.
PubMed
Journal
Adv Exp Med Biol
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
4.18
iCite
Revised in PubMed
2024-02-21
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bonifácio VDBVasco D B

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Early Detection of CancerMajor topic
Ovarian NeoplasmsMajor topic
CA-125 Antigen
Female
Humans
Proteomics

Source PubMed

Download CSV of topics

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115199385Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer.Br J Cancer2004https://conductscience.org/library/papers/15199385PubMed
216220531Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.Proteomics2005https://conductscience.org/library/papers/16220531PubMed
329662629Pre-diagnostic biomarkers of metabolic dysregulation and cancer mortality.Oncotarget2018https://conductscience.org/library/papers/29662629PubMed
416674097Comparative proteomics of ovarian epithelial tumors.J Proteome Res2006https://conductscience.org/library/papers/16674097PubMed
512488461The human plasma proteome: history, character, and diagnostic prospects.Mol Cell Proteomics2002https://conductscience.org/library/papers/12488461PubMed
619007973Urinary levels of Bcl-2 are elevated in ovarian cancer patients.Gynecol Oncol2009https://conductscience.org/library/papers/19007973PubMed
717532030Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.Gynecol Oncol2007https://conductscience.org/library/papers/17532030PubMed
810228898CA 125: the past and the future.Int J Biol Markers1998https://conductscience.org/library/papers/10228898PubMed
915266667Discovery of ovarian cancer biomarkers in serum using NanoLC electrospray ionization TOF and FT-ICR mass spectrometry.Dis Markers2003https://conductscience.org/library/papers/15266667PubMed
1029430218Metabolomic characterization of experimental ovarian cancer ascitic fluid.Metabolomics2017https://conductscience.org/library/papers/29430218PubMed
1116428467Ovarian cancer biomarkers in urine.Clin Cancer Res2006https://conductscience.org/library/papers/16428467PubMed
1225225597In 2014, can we do better than CA125 in the early detection of ovarian cancer?World J Biol Chem2014https://conductscience.org/library/papers/25225597PubMed
1326970494Validation of a second-generation multivariate index assay for malignancy risk of adnexal masses.Am J Obstet Gynecol2016https://conductscience.org/library/papers/26970494PubMed
1429038145Oncometabolites: A New Paradigm for Oncology, Metabolism, and the Clinical Laboratory.Clin Chem2017https://conductscience.org/library/papers/29038145PubMed
1527381498Level of HE4 is Correlated with Diagnosis of Struma Ovarii: A Case Report.Am J Case Rep2016https://conductscience.org/library/papers/27381498PubMed
1620071014Urinary angiostatin levels are elevated in patients with epithelial ovarian cancer.Gynecol Oncol2010https://conductscience.org/library/papers/20071014PubMed
1725736266Proteomics of ovarian cancer: functional insights and clinical applications.Cancer Metastasis Rev2015https://conductscience.org/library/papers/25736266PubMed
1823485231Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.Eur J Cancer2013https://conductscience.org/library/papers/23485231PubMed
1930429787Tumor Microenvironment Targeted Nanotherapy.Front Pharmacol2018https://conductscience.org/library/papers/30429787PubMed
2029244844Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.PLoS One2017https://conductscience.org/library/papers/29244844PubMed

See all 67 referencesDownload CSV of references

Cited by69

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
42973469
A modified ovarian-adnexal reporting and data system ultrasound for differentiating ovarian carcinoma: integration of the risk of malignancy algorithm into the American College of Radiology's O-RADS US framework.
Front Oncol2026https://conductscience.org/library/papers/42973469PubMed
42601376The phosphoproteome of ovarian carcinoma delineates signaling signatures and potentially druggable targets across histotype stages.NPJ Precis Oncol2026https://conductscience.org/library/papers/42601376PubMed
42451690Construction of a Near-Infrared Viscosity Fluorescent Probe Targeting Mitochondria and Study on Its pH-Coordinated Effect.Molecules2026https://conductscience.org/library/papers/42451690PubMed
42350421Potent anti-tumor activity of CD98hc-targeted antibody-drug conjugates in ovarian cancer.Signal Transduct Target Ther2026https://conductscience.org/library/papers/42350421PubMed
41969514Low LAMA2 expression may affect drug resistance and prognosis in ovarian cancer via positive LGR5 coexpression.Transl Cancer Res2026https://conductscience.org/library/papers/41969514PubMed
41772713Molecular and cellular landscapes of the immune microenvironment and multiomic biomarker-sets in platinum-resistant recurrent ovarian cancers.J Ovarian Res2026https://conductscience.org/library/papers/41772713PubMed
41731152Au-decorated NiYFe-LDH/MWCNT nanohybrid-based high-performance immunosensor for ultrasensitive electrochemical detection of cancer antigen 125.Mikrochim Acta2026https://conductscience.org/library/papers/41731152PubMed
41376855Platinum-resistant ovarian cancer: From mechanisms to treatment strategies.Genes Dis2026https://conductscience.org/library/papers/41376855PubMed
410181126-gingerol promotes apoptosis of ovarian cancer cells through miR-506/Gli3 signaling pathway activation.Front Oncol2025https://conductscience.org/library/papers/41018112PubMed
40943317The OvarianTag™ Biomarker Panel Emerges as a Prognostic Tool to Guide Clinical Decisions in Cisplatin-Based Treatment of Epithelial Ovarian Cancer.Int J Mol Sci2025https://conductscience.org/library/papers/40943317PubMed
40778374Unveiling histotype-specific biomarkers in ovarian carcinoma using proteomics.Mol Ther Oncol2025https://conductscience.org/library/papers/40778374PubMed
40605080The role and therapeutic value of NUSAP1 in human cancers.J Transl Med2025https://conductscience.org/library/papers/40605080PubMed
40463490Diagnostic Value of PET/CT for Ovarian Cancer Recurrence or Metastasis in Postoperative Patients With Elevated Serum CA125 Levels: A Systematic Review and Meta-Analysis.Cancer Innov2025https://conductscience.org/library/papers/40463490PubMed
40372993Characterization of small extracellular vesicles from ovarian cancer patients and pre-diagnostic patient samples: Evidence from the Danish blood donor study.PLoS One2025https://conductscience.org/library/papers/40372993PubMed
40358150On the Quest for Biomarkers: A Comprehensive Analysis of Modified Nucleosides in Ovarian Cancer Cell Lines.Cells2025https://conductscience.org/library/papers/40358150PubMed
40038842Investigation of the mechanism by which FOXJ2 inhibits proliferation, metastasis and cell cycle progression of ovarian cancer cells through the PI3K/AKT signaling pathway.Eur J Med Res2025https://conductscience.org/library/papers/40038842PubMed
39839766Opportunities for predictive proteogenomic biomarkers of drug treatment sensitivity in epithelial ovarian cancer.Front Oncol2024https://conductscience.org/library/papers/39839766PubMed
39744561MiR-675 Inhibits Primary Ovarian Tumor Growth and Metastasis by Suppressing EMT and TGFβ Signaling.J Cancer2025https://conductscience.org/library/papers/39744561PubMed
39588300Drug resistance biomarkers in ovarian cancer: a bibliometric study from 2017 to 2022.Front Oncol2024https://conductscience.org/library/papers/39588300PubMed
39479573Sensitive and Cost-Effective Tools in the Detection of Ovarian Cancer Biomarkers.Anal Sci Adv2024https://conductscience.org/library/papers/39479573PubMed

See all 69 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MUC1694025PubTator's text mininghttps://conductscience.org/library/genes/94025

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32130708

GET https://conductscience.org/api/papers/v1/32130708/references?page=2